Font Size: a A A
Keyword [Imatinib]
Result: 21 - 40 | Page: 2 of 10
21. A Study On The Underlying Mechanism Of Imatinib-aquired Resistance In Gastrointestinal Stromal Tumors
22. The Effects Of Calmodulin Antagonist Tetrandrine Citrate On The Growth In Vitro And In Vivo Of Chronic Myeloid Leukemia And Its Mechanisms
23. The Study Of Trichostatin A On Imatinib Resistant Chronic Myeloid Leukemia Cells
24. Detection Of PTP Activity And Sequencing Of ATP Binding Domain Of Bcr-Abl Gene In Chronic Myeloid Leukemia Resistant To STI571
25. Clinical Analysis And Therapeutic Application Of Imatinib In Gastrointestinal Stromal Tumors
26. Diagnosis And Treatment Of Gastric Stromal Tumors: A Report Of 61 Cases
27. Efficacy And Safety Evaluation Of Imatinib In The Treatment Of Patients With Gastrointestinal Stromal Tumors In High Risk Of Recurrence And In Advanced Stages
28. To Detect The Expression Of HOCT1 By Semi-quantity RT-PCR In Chronic Myelogeneous Leukemia Patients Administered By Imatinib Mesylate
29. Establishment And Study Of An Imatinib Resistance Cell Line K562R
30. Monitoring BCR-ABL Fusion Gene By Real Time Quantitative PCR In Chronic Myelogenous Leukemia Patients Treated With Imatinib Mesylate
31. Clinical Efficacy Of Imatinib Meylate In Treatment Of Patients With Chronic Myeloid Leukemia In Advanced Phase
32. Effect Of JNK And Bim In K562 Leukemia Cell Resistance To Imatinib, KR
33. Clinical Effect Of Imatinib On Gastrointestinal Stromal Tumors
34. Effects Of Imatinib And Rapamycin On MTOR/S6 Signal Transduction Pathway In CD33~+ Cell And Immunity Of T Cell In CML
35. The Study Of Monitoring In Imatinib-resistant Chronic Myeloid Leukemia Patients
36. The Efficacy Analysis Of Imatinib To The Chronic Myeloid Leukemia
37. The Effect Of Arsenic Trioxide On Imatinib-Resistant Cell Lines K562R And KBM5R
38. Research Progress Of Gastrointestinal Stromal Tumors
39. The Effect Of Imatinib Mesylate Therapy On Ph Chromosome And Bcr/abl Gene Expression In Patients With CML
40. The Analysis Of Therapeutic Effects And Drug-resistance Of Imatinib On 117 Patients With Chronic Myeloid Leukemia
  <<First  <Prev  Next>  Last>>  Jump to